GLOBAL BIOSURGERY MARKET 2019-2027

MARKET OUTLOOK
The global biosurgery market is expected to progress at a CAGR of 8.51% over the forecast period of 2019-2027. Some of the factors that are responsible for driving the biosurgery market are the growth in joint reconstruction and spinal fusion, growth the rate of surgeries due to several lifestyle disorders and the rise in the overweight & aging population. The major challenges faced by the global biosurgery market are the lack of significant differentiation in the variety of products, side-effects & FDA inquiry and complications related to immune response.
The increasing research & investment in bioengineering and the growing healthcare spending & development policy for compensation and reimbursement are some of the key opportunities for the growth of the market in the coming years. The major restraints in the market include stringent regulatory approval, the high cost of surgeries, rising usage of minimally invasive surgeries and lack of awareness. The Triton Market Research report on the biosurgery market is segmented into products, application and source type.
REGIONAL OUTLOOK
The regions studied in the global biosurgery market report are North America, Europe, Asia-Pacific and rest of the world, which includes Latin America, the Middle East and Africa. North America leads the global biosurgery market by possessing the largest share of the global market. Asia-Pacific is predicted to be the fastest-growing region in terms of CAGR over the forecasting years. The growth of the market in this region is owing to the rising investments by top players in this region and developing healthcare industry. Moreover, the rising aging population is increasing the patient population in this region, which is also boosting the biosurgery market.
COMPETITIVE OUTLOOK
The major players in the market include Olympus Corporation, Smith & Nephew Plc, Ethicon, Inc., Ypsomed Holding AG, Johnson & Johnson, Medtronic Plc, B. Braun Melsungen AG, Baxter International, Inc., Stryker Corporation, RTI Surgical, Sanofi, Zimmer Biomet Holdings, Inc. and Wright Medical Group N.V.
B. Braun Melsungen AG is a medical and pharmaceutical device company. The company is engaged in the manufacture, marketing and selling of numerous healthcare products and services for ICUs, anesthetic and emergency care at a global scale. In 2015, the company acquired the German-based manufacturer Lauer Membran Wassertechnik. Through the acquisition, B. Braun expanded its portfolio of water treatment systems for dialysis.

TABLE OF CONTENTS
1. BIOSURGERY MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. TRENDS IN BIOSURGERY TECHNOLOGY
2.3. REGULATORY FRAMEWORK
2.4. KEY VENDORS OUTLOOK
2.5. KEY INSIGHTS
2.6. KEY BUYING OUTLOOK
2.7. KEY PATENT OUTLOOK
2.7.1. EUROPE
2.7.2. THE UNITED STATES
2.7.3. ASIA-PACIFIC
2.7.3.1. JAPAN PATENT ANALYSIS
2.7.3.2. CHINA PATENT ANALYSIS
2.7.3.3. KOREA PATENT ANALYSIS
2.8. MARKET DRIVERS
2.8.1. AGING POPULATION
2.8.2. SURGE IN SURGICAL TREATMENTS FOR MUSCULOSKELETAL DISORDERS
2.8.3. RISE IN SPINAL FUSION AND JOINT RECONSTRUCTION
2.8.4. SURGE IN THE OVERWEIGHT POPULATION
2.8.5. INCREASING TRAUMA-RELATED WOUNDS
2.9. MARKET RESTRAINTS
2.9.1. STRINGENT REGULATORY APPROVAL
2.9.2. INCREASE IN THE COST OF SURGERIES
2.9.3. INCREASING USAGE OF MINIMALLY INVASIVE SURGERIES
2.9.4. LACK OF AWARENESS
2.10. MARKET OPPORTUNITIES
2.10.1. DEVELOPMENT OF POLICY FOR REIMBURSEMENT AND COMPENSATION
2.10.2. INCREASE IN RESEARCH AND INVESTMENT IN BIOENGINEERING
2.10.3. INCREASE IN HEALTHCARE SPENDING
2.11. MARKET CHALLENGES
2.11.1. AMPLIFIED SCRUTINY OF STEM CELL-DERIVED PRODUCTS
2.11.2. COMPLICATION RELATED TO IMMUNE RESPONSE
2.11.3. LACK OF SIGNIFICANT DIFFERENTIATION IN THE RANGE OF PRODUCTS
2.11.4. PRODUCT SIDE-EFFECTS AND FDA INQUIRY
3. BIOSURGERY MARKET OUTLOOK - BY PRODUCTS
3.1. BONE-GRAFT SUBSTITUTES
3.1.1. SYNTHETIC GRAFT EXTENDER
3.1.2. DEMINERALIZED BONE MATRIX
3.1.3. BONE MORPHOGENETIC PROTEINS
3.1.4. CELL-BASED MATRICES
3.2. HEMOSTATIC AGENTS
3.3. SOFT-TISSUE MANAGEMENT
3.3.1. SYNTHETIC MESH/PATCH
3.3.2. NATURAL MESH/PATCH
3.4. SURGICAL SEALING AGENTS
3.4.1. NATURAL SURGICAL SEALING AGENTS
3.4.2. SYNTHETIC SURGICAL SEALING AGENTS
3.5. ANTI-ADHESIVE AGENTS
4. BIOSURGERY MARKET OUTLOOK - BY APPLICATION
4.1. NEURO AND SPINE SURGERY
4.2. CARDIO AND THORACIC SURGERY
4.3. GENERAL SURGERY
4.4. ORTHOPEDIC SURGERY
5. BIOSURGERY MARKET OUTLOOK - BY SOURCE TYPE
5.1. NATURAL
5.2. SYNTHETIC
6. BIOSURGERY MARKET - REGIONAL OUTLOOK
6.1. NORTH AMERICA
6.1.1. MARKET BY PRODUCTS
6.1.2. MARKET BY APPLICATION
6.1.3. MARKET BY SOURCE TYPE
6.1.4. COUNTRY ANALYSIS
6.1.4.1. THE UNITED STATES
6.1.4.2. CANADA
6.2. EUROPE
6.2.1. MARKET BY PRODUCTS
6.2.2. MARKET BY APPLICATION
6.2.3. MARKET BY SOURCE TYPE
6.2.4. COUNTRY ANALYSIS
6.2.4.1. GERMANY
6.2.4.2. THE UNITED KINGDOM
6.2.4.3. FRANCE
6.2.4.4. REST OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. MARKET BY PRODUCTS
6.3.2. MARKET BY APPLICATION
6.3.3. MARKET BY SOURCE TYPE
6.3.4. COUNTRY ANALYSIS
6.3.4.1. CHINA
6.3.4.2. JAPAN
6.3.4.3. INDIA
6.3.4.4. AUSTRALIA
6.3.4.5. REST OF ASIA-PACIFIC
6.4. LATIN AMERICA
6.4.1. MARKET BY PRODUCTS
6.4.2. MARKET BY APPLICATION
6.4.3. MARKET BY SOURCE TYPE
6.4.4. COUNTRY ANALYSIS
6.4.4.1. BRAZIL
6.4.4.2. MEXICO
6.4.4.3. REST OF LATIN AMERICA
6.5. MIDDLE EAST AND AFRICA
6.5.1. MARKET BY PRODUCTS
6.5.2. MARKET BY APPLICATION
6.5.3. MARKET BY SOURCE TYPE
6.5.4. COUNTRY ANALYSIS
6.5.4.1. SAUDI ARABIA
6.5.4.2. TURKEY
6.5.4.3. THE UNITED ARAB EMIRATES
6.5.4.4. SOUTH AFRICA
6.5.4.5. REST OF MIDDLE EAST AND AFRICA
7. COMPETITIVE LANDSCAPE
7.1. B. BRAUN MELSUNGEN AG
7.2. JOHNSON & JOHNSON
7.3. BAXTER INTERNATIONAL, INC.
7.4. ETHICON, INC.
7.5. MEDTRONIC PLC
7.6. SANOFI
7.7. OLYMPUS CORPORATION
7.8. RTI SURGICAL
7.9. SMITH & NEPHEW PLC
7.10. STRYKER CORPORATION
7.11. ZIMMER BIOMET HOLDINGS, INC.
7.12. WRIGHT MEDICAL GROUP N.V.
7.13. YPSOMED HOLDING AG
8. METHODOLOGY AND SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY



TABLE LIST
TABLE 1 GLOBAL BIOSURGERY MARKET BY REGION 2019-2027 (IN $ MILLION)
TABLE 2 MEDICAL DEVICE CLASSIFICATION
TABLE 3 TYPES OF PMA SUPPLEMENTS
TABLE 4 MEDICAL DEVICES BY CLASS
TABLE 5 RULES AND REGULATIONS IN JAPAN
TABLE 6 REGISTRATION/APPROVAL OF PATENTS GLOBALLY 2010-2016 (%)
TABLE 7 GLOBAL BIOSURGERY MARKET BY PRODUCTS 2019-2027 (IN $ MILLION)
TABLE 8 DIFFERENT TYPES OF BONE-GRAFT SUBSTITUTES
TABLE 9 GLOBAL BIOSURGERY MARKET IN BONE-GRAFT SUBSTITUTES BY TYPES 2019-2027 (IN $ MILLION)
TABLE 10 KEY OSTEOBIOLOGIC PRODUCTS AVAILABLE IN THE MARKET
TABLE 11 KEY SOFT TISSUE-MANAGEMENT PRODUCTS AVAILABLE IN THE MARKET
TABLE 12 GLOBAL BIOSURGERY MARKET IN SOFT-TISSUE MANAGEMENT BY TYPES 2019-2027 (IN $ MILLION)
TABLE 13 KEY SURGICAL SEALING AGENTS AVAILABLE IN THE MARKET
TABLE 14 GLOBAL BIOSURGERY MARKET IN SURGICAL SEALING AGENTS BY TYPES 2019-2027 (IN $ MILLION)
TABLE 15 GLOBAL BIOSURGERY MARKET BY APPLICATIONS 2019-2027 (IN $ MILLION)
TABLE 16 TYPES OF CARDIOVASCULAR DISEASES
TABLE 17 STAGES OF GRAFT HEALING AND THEIR CHARACTERISTICS
TABLE 18 GLOBAL BIOSURGERY MARKET BY SOURCE TYPE 2019-2027 (IN $ MILLION)
TABLE 19 NORTH AMERICA BIOSURGERY MARKET BY PRODUCTS 2019-2027 (IN $ MILLION)
TABLE 20 NORTH AMERICA BIOSURGERY MARKET BY APPLICATION 2019-2027 (IN $ MILLION)
TABLE 21 NORTH AMERICA BIOSURGERY MARKET BY SOURCE TYPE 2019-2027 (IN $ MILLION)
TABLE 22 NORTH AMERICA BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)
TABLE 23 EUROPE BIOSURGERY MARKET BY PRODUCTS 2019-2027 (IN $ MILLION)
TABLE 24 EUROPE BIOSURGERY MARKET BY APPLICATION 2019-2027 (IN $ MILLION)
TABLE 25 EUROPE BIOSURGERY MARKET BY SOURCE TYPE 2019-2027 (IN $ MILLION)
TABLE 26 EUROPE BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)
TABLE 27 ASIA-PACIFIC BIOSURGERY MARKET BY PRODUCTS 2019-2027 (IN $ MILLION)
TABLE 28 ASIA-PACIFIC BIOSURGERY MARKET BY APPLICATION 2019-2027 (IN $ MILLION)
TABLE 29 ASIA-PACIFIC BIOSURGERY MARKET BY SOURCE TYPE 2019-2027 (IN $ MILLION)
TABLE 30 ASIA-PACIFIC BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)
TABLE 31 LATIN AMERICA BIOSURGERY MARKET BY PRODUCTS 2019-2027 (IN $ MILLION)
TABLE 32 LATIN AMERICA BIOSURGERY MARKET BY APPLICATION 2019-2027 (IN $ MILLION)
TABLE 33 LATIN AMERICA BIOSURGERY MARKET BY SOURCE TYPE 2019-2027 (IN $ MILLION)
TABLE 34 LATIN AMERICA BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)
TABLE 35 MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY PRODUCTS 2019-2027 (IN $ MILLION)
TABLE 36 MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY APPLICATION 2019-2027 (IN $ MILLION)
TABLE 37 MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY SOURCE TYPE 2019-2027 (IN $ MILLION)
TABLE 38 MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)





FIGURES LIST
FIGURE 1 GLOBAL BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 2 KEY STRATEGIES IN BIOSURGERY MARKET
FIGURE 3 EUROPE PATENT ANALYSIS BY PRODUCT 2010-2016 (%)
FIGURE 4 EUROPE PATENT ANALYSIS BY MARKET PARTICIPANT 2010-2016
FIGURE 5 U.S. PATENT ANALYSIS ON THE BASIS OF PRODUCT 2010-2016
FIGURE 6 U.S. PATENT ANALYSIS BY MARKET PARTICIPANT 2010-2016 (%)
FIGURE 7 JAPAN PATENT ANALYSIS BY PRODUCT 2010-2016
FIGURE 8 JAPAN PATENT ANALYSIS BY MARKET PARTICIPANT 2010-2016
FIGURE 9 CHINA PATENT ANALYSIS BY PRODUCT 2010-2016
FIGURE 10 CHINA PATENT ANALYSIS BY MARKET PARTICIPANT 2010-2016
FIGURE 11 KOREA PATENT ANALYSIS BY PRODUCT 2010-2016
FIGURE 12 KOREA PATENT ANALYSIS BY MARKET PARTICIPANT 2010-2016
FIGURE 13 LIFE EXPECTANCY OF GERIATRIC POPULATION GLOBALLY 2010-2050
FIGURE 14 PERCENTAGE DISTRIBUTION OF POPULATION AGED ABOVE 65, 2015 & 2050
FIGURE 15 PER CAPITA HEALTH EXPENDITURES FOR TOP COUNTRIES (%)
FIGURE 16 DIFFERENT TYPES OF NATURAL BIOSURGICAL SEALANTS
FIGURE 17 GLOBAL BIOSURGERY MARKET IN BONE-GRAFT SUBSTITUTES 2019-2027 (IN $ MILLION)
FIGURE 18 GLOBAL BIOSURGERY MARKET IN HEMOSTATIC AGENTS 2019-2027 (IN $ MILLION)
FIGURE 19 GLOBAL BIOSURGERY MARKET IN SOFT-TISSUE MANAGEMENT 2019-2027 (IN $ MILLION)
FIGURE 20 GLOBAL BIOSURGERY MARKET IN SURGICAL SEALING AGENTS 2019-2027 (IN $ MILLION)
FIGURE 21 GLOBAL BIOSURGERY MARKET IN ANTI-ADHESIVE AGENTS 2019-2027 (IN $ MILLION)
FIGURE 22 GLOBAL BIOSURGERY MARKET IN NEURO AND SPINE SURGERY 2019-2027 (IN $ MILLION)
FIGURE 23 GLOBAL BIOSURGERY MARKET IN CARDIO AND THORACIC SURGERY 2019-2027 (IN $ MILLION)
FIGURE 24 GLOBAL BIOSURGERY MARKET IN GENERAL SURGERY 2019-2027 (IN $ MILLION)
FIGURE 25 GLOBAL BIOSURGERY MARKET IN ORTHOPEDIC SURGERY 2019-2027 (IN $ MILLION)
FIGURE 26 GLOBAL BIOSURGERY MARKET IN NATURAL 2019-2027 (IN $ MILLION)
FIGURE 27 GLOBAL BIOSURGERY MARKET IN SYNTHETIC 2019-2027 (IN $ MILLION)
FIGURE 28 BIOSURGERY RESEARCH PROJECTS PATENT BY DIFFERENT ORGANIZATIONS 2016 (%)
FIGURE 29 NORTH AMERICA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 30 THE UNITED STATES BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 31 DIABETES PREVALENCE AMONG DIFFERENT AMERICAN ETHNICITIES (%)
FIGURE 32 CANADA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 33 EUROPE BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 34 RATE OF CHRONIC DISORDERS IN EUROPE 2016 (%)
FIGURE 35 GERMANY BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 36 THE UNITED KINGDOM BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 37 FRANCE BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 38 REST OF EUROPE BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 39 ASIA-PACIFIC BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 40 CHINA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 41 RATE OF GERIATRIC POPULATION STATISTICS, BY AGE IN JAPAN (%)
FIGURE 42 JAPAN BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 43 INDIA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 44 AUSTRALIA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 45 REST OF ASIA-PACIFIC BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 46 BRAZIL BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)
FIGURE 47 MEXICO BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)
FIGURE 48 REST OF LATIN AMERICA BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)
FIGURE 49 SAUDI ARABIA BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)
FIGURE 50 TURKEY BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)
FIGURE 51 THE UNITED ARAB EMIRATES BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)
FIGURE 52 SOUTH AFRICA BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)
FIGURE 53 REST OF MIDDLE EAST AND AFRICA DENTAL DIAGNOSTICS AND SURGICAL EQUIPMENT MARKET 2019-2027 (IN $ MILLION)